Kliman Gilbert H 4
4 · GLAUKOS Corp · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
GLAUKOS Director Gilbert Kliman Exercises Options, Sells Shares
What Happened
Gilbert H. Kliman, a director of GLAUKOS Corp (GKOS), exercised stock options and sold shares on May 11, 2026. He exercised a total of 10,000 option shares (two exercises of 5,000 each) at an exercise price of $24.69 per share (total exercise amount $246,900). Immediately after, 5,000 shares were sold in the open market at $135.00 per share for proceeds of $675,000, and 5,000 shares were surrendered/used in the derivative transaction (valued at $123,450) consistent with covering exercise costs or tax withholding.
Key Details
- Transaction date: May 11, 2026 (reported on Form 4 filed May 13, 2026) — appears timely (filed within 2 business days)
- Exercise details: 10,000 option shares exercised at $24.69 per share (two 5,000-share exercises; total exercise cost $246,900)
- Sale details: 5,000 shares sold on the open market at $135.00 per share; proceeds $675,000
- Surrendered shares: 5,000 shares were disposed in the derivative transaction at $24.69 (value $123,450), likely to cover exercise price/taxes
- Shares owned after transaction: Not specified in the provided summary; filing notes include 2,731 restricted stock units that are unvested or delivery‑deferred (see footnote F1)
- Footnotes: F1 notes RSUs (2,731) unvested or delivery‑deferred; F2 notes the option was granted June 2, 2016 and fully vested one year later
Context
This was an option exercise followed by an immediate partial sale — a common pattern when insiders exercise vested options and sell shares to cover the exercise cost and taxes (often described as a cashless exercise). The options exercised were long‑vested (granted in 2016, fully vested in 2017 per F2). Sales by insiders can be routine (tax/transaction related) and do not by themselves confirm a change in sentiment; purchases generally convey stronger positive signals. For full ownership details and exact beneficial holdings after the transactions, consult the filed Form 4 (Accession 0001293171-26-000004).
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-05-11$24.69/sh+5,000$123,450→ 40,528 total - Sale
Common Stock
[F1]2026-05-11$135.00/sh−5,000$675,000→ 35,528 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-05-11$24.69/sh−5,000$123,450→ 5,000 totalExercise: $24.69From: 2017-06-02Exp: 2026-06-02→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
- [F2]This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date.